Study reveals non-statin cholesterol drugs could reduce liver cancer risk
The third leading cause of cancer mortality accounts for over 700,000 deaths every year
Read More
Tag: non-statin cholesterol drugs
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
